Bristol-Myers Squibb Company
BMY
•Stock Analysis$46.35
+0.00 (+0.00%)• Live
Bristol-Myers Squibb Company Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Bristol-Myers Squibb Company
Key Financial Metrics
for Bristol-Myers Squibb Company
P/E Ratio
18.73
Revenue Growth
+7.32%
EPS Growth
-213.66%
Market Cap
$101.69B
Dividend Yield
+4.88%
Debt/Equity
2.95
ROIC
+10.85%
FCF Yield
+12.87%
View additional metrics
Valuation
P/B Ratio5.84
EV/Sales2.98
Financial Health
Current Ratio1.28
Return on Assets+11.24%
Analyst Recommendations
for Bristol-Myers Squibb Company
40 analysts
Consensus: Hold
About
for Bristol-Myers Squibb Company
Company Details
for Bristol-Myers Squibb Company
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christopher S. Boerner
Employees
34,100
Market Cap
94.33B
Exchange
New York Stock Exchange
IPO Date
June 1, 1972
Website
www.bms.comCIK
0000014272
ISIN
US1101221083
CUSIP
110122108
Country
US
Balance Sheet
for Bristol-Myers Squibb Company
Cash Flow Statement
for Bristol-Myers Squibb Company
Income Statement
for Bristol-Myers Squibb Company
News
No news available at the moment.